Skip to main content
AMPH logo
AMPH
(NASDAQ)
Amphastar Pharmaceuticals, Inc.
$21.98-- (--)
Loading... - Market loading

Amphastar Pharmaceuticals (AMPH) Stock Price & Financial Analysis

Amphastar Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$21.41 - $22.07
52-Week High$31.26
52-Week Low$16.65
Open$21.50
Volume283.72K
Average Volume (3M)433.04K
Market Cap1.02B
Shares Outstanding46.46M
P/E Ratio (TTM)12.89
Forward P/E23.49
Price to Sales (P/S)1.42
Price to Book (P/B)1.32
EV/EBITDA8.03
Revenue (TTM)720.53M
Net Income (TTM)79.23M
Free Cash Flow (TTM)135.19M
EPS (TTM)$1.67
Profit Margin11.00%
Operating Margin16.20%
Return on Equity (ROE)10.24%
Debt to Equity0.89
50-Day MA$20.07
200-Day MA$22.65
52-Week Change-26.32%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Amphastar Pharmaceuticals

What is the current stock price for AMPH?

As of the latest trading session, AMPH stock trades at $21.98. The 52-week range is $16.65–$31.26, with a day range of $21.41–$22.07.

What is the P/E ratio for AMPH?

Amphastar Pharmaceuticals's trailing P/E ratio is 12.9, meaning investors pay $12.9 for every $1 of annual earnings. The forward P/E is 23.5, reflecting analyst expectations for future earnings. Amphastar Pharmaceuticals operates in the Healthcare sector.

Does AMPH pay dividends?

Amphastar Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AMPH?

Based on 3 analysts, the consensus for AMPH is Sell.

What is the market cap of AMPH?

Amphastar Pharmaceuticals's market capitalization is $1.02B, classifying it as a small-cap company. Amphastar Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.